Injectable Tirzepatide

Compounded Tirzepatide is a patient-specific medication prescribed by a licensed healthcare provider following an individualized medical evaluation. It is prepared by a licensed U.S. compounding pharmacy registered under Section 503A or by a 503B FDA-registered outsourcing facility.

Compounded medications are not reviewed or approved by the U.S. Food and Drug Administration (FDA). As such, they may differ from FDA-approved products in terms of safety, effectiveness, quality, and potential side effects. Data from clinical studies on FDA-approved medications should not be assumed to apply to compounded versions.

Weight Loss MD works exclusively with licensed U.S.-based compounding pharmacies that operate in accordance with applicable federal and state regulations.